Hettiarachchi J - Search Results

1

No effect of eletriptan administration during the aura phase of migraine.

Olesen J, Diener HC, Schoenen J, Hettiarachchi J. Olesen J, et al. Among authors: hettiarachchi j. Eur J Neurol. 2004 Oct;11(10):671-7. doi: 10.1111/j.1468-1331.2004.00914.x. Eur J Neurol. 2004. PMID: 15469451 Clinical Trial.

2

The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg.

Diener HC, Ryan R, Sun W, Hettiarachchi J. Diener HC, et al. Among authors: hettiarachchi j. Eur J Neurol. 2004 Feb;11(2):125-34. doi: 10.1046/j.1351-5101.2003.00730.x. Eur J Neurol. 2004. PMID: 14748774

3

No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials.

Roon KI, Olesen J, Diener HC, Ellis P, Hettiarachchi J, Poole PH, Christianssen I, Kleinermans D, Kok JG, Ferrari MD. Roon KI, et al. Among authors: hettiarachchi j. Ann Neurol. 2000 Feb;47(2):238-41. Ann Neurol. 2000. PMID: 10665496 Clinical Trial.

4

Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan.

Schoenen J, Pascual J, Rasmussen S, Sun W, Sikes C, Hettiarachchi J. Schoenen J, et al. Among authors: hettiarachchi j. Eur J Neurol. 2005 Feb;12(2):108-17. doi: 10.1111/j.1468-1331.2004.00893.x. Eur J Neurol. 2005. PMID: 15679698 Clinical Trial.

5

Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.

Garcia-Ramos G, MacGregor EA, Hilliard B, Bordini CA, Leston J, Hettiarachchi J. Garcia-Ramos G, et al. Among authors: hettiarachchi j. Cephalalgia. 2003 Nov;23(9):869-76. doi: 10.1046/j.1468-2982.2003.00593.x. Cephalalgia. 2003. PMID: 14616928 Clinical Trial.

6

Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders.

Diamond ML, Hettiarachchi J, Hilliard B, Sands G, Nett R. Diamond ML, et al. Among authors: hettiarachchi j. Headache. 2004 Mar;44(3):209-16. doi: 10.1111/j.1526-4610.2004.04049.x. Headache. 2004. PMID: 15012657 Clinical Trial.

7

Efficacy, safety and tolerability of oral eletriptan in the acute treatment of migraine: results of a phase III, multicentre, placebo-controlled study across three attacks.

Stark R, Dahlöf C, Haughie S, Hettiarachchi J; Eletriptan Steering Committee. Stark R, et al. Among authors: hettiarachchi j. Cephalalgia. 2002 Feb;22(1):23-32. doi: 10.1046/j.1468-2982.2002.00300.x. Cephalalgia. 2002. PMID: 11993610 Clinical Trial.

8

Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review.

Mathew NT, Hettiarachchi J, Alderman J. Mathew NT, et al. Among authors: hettiarachchi j. Headache. 2003 Oct;43(9):962-74. doi: 10.1046/j.1526-4610.2003.03188.x. Headache. 2003. PMID: 14511273 Review.

9

Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.

Martin VT, Valade D, Almas M, Hettiarachchi J, Sikes C, Albert KS, Parsons B. Martin VT, et al. Among authors: hettiarachchi j. Headache. 2007 Feb;47(2):181-8. doi: 10.1111/j.1526-4610.2006.00685.x. Headache. 2007. PMID: 17300357 Clinical Trial.

10

A self-administered screener for migraine in primary care: The ID Migraine validation study.

Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W; ID Migraine validation study. Lipton RB, et al. Among authors: hettiarachchi j. Neurology. 2003 Aug 12;61(3):375-82. doi: 10.1212/01.wnl.0000078940.53438.83. Neurology. 2003. PMID: 12913201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters